Name: Can-Fite BioPharma
Address: 10 Bareket Street, Petah-Tikva, 49170, ISRAEL
Telephone: +972-3-9241114

Filing Type:

Year:

Date	Form	Description	Pages
02/16/21	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	5
02/09/21	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	7
02/01/21	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	2
01/29/21	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	6
01/28/21	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	2
01/08/21	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	3
12/15/20	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	6
12/14/20	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	3
12/09/20	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments	3
12/02/20	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments	3